pneumococcus conjugate vaccine 7 valent to reduce carriage
ApprovedCompleted 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Vaccines, Pneumococcal
Conditions
Vaccines, Pneumococcal, Vaccines, Pneumococcal Conjugate Vaccine
Trial Timeline
Sep 1, 2003 → Aug 1, 2004
NCT ID
NCT00580684About pneumococcus conjugate vaccine 7 valent to reduce carriage
pneumococcus conjugate vaccine 7 valent to reduce carriage is a approved stage product being developed by Pfizer for Vaccines, Pneumococcal. The current trial status is completed. This product is registered under clinical trial identifier NCT00580684. Target conditions include Vaccines, Pneumococcal, Vaccines, Pneumococcal Conjugate Vaccine.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00580684 | Approved | Completed |
Competing Products
20 competing products in Vaccines, Pneumococcal